JP2016020396A5 - - Google Patents

Download PDF

Info

Publication number
JP2016020396A5
JP2016020396A5 JP2015215222A JP2015215222A JP2016020396A5 JP 2016020396 A5 JP2016020396 A5 JP 2016020396A5 JP 2015215222 A JP2015215222 A JP 2015215222A JP 2015215222 A JP2015215222 A JP 2015215222A JP 2016020396 A5 JP2016020396 A5 JP 2016020396A5
Authority
JP
Japan
Prior art keywords
antibody
ion channel
fragment
binds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015215222A
Other languages
Japanese (ja)
Other versions
JP2016020396A (en
JP6335152B2 (en
Filing date
Publication date
Priority claimed from GBGB0922434.6A external-priority patent/GB0922434D0/en
Application filed filed Critical
Publication of JP2016020396A publication Critical patent/JP2016020396A/en
Publication of JP2016020396A5 publication Critical patent/JP2016020396A5/ja
Application granted granted Critical
Publication of JP6335152B2 publication Critical patent/JP6335152B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

イオンチャネルのE1細胞外ループに結合する、抗E1イオンチャネル抗体又はその結合断片であって、
前記イオンチャネルが疼痛の調節において機能し、前記抗体又は断片が前記イオンチャネルを、それに結合した後、機能的に改変し
イオンチャネルが、Na 1.3、1.6、1.8、及び1.9からなる群から選択されるナトリウムイオンチャネルであり;
イオンチャネルのドメインB又はドメインCにおけるE1ループに結合する上記抗体又はその結合断片。
An anti-E1 ion channel antibody or binding fragment thereof that binds to the E1 extracellular loop of an ion channel, comprising:
The ion channel functions in the regulation of pain, and the antibody or fragment functionally modifies after binding the ion channel to the ion channel ;
The ion channel is a sodium ion channel selected from the group consisting of Na v 1.3, 1.6, 1.8, and 1.9;
The antibody or the binding fragment thereof, which binds to the E1 loop in domain B or domain C of the ion channel .
抗体又はその断片が、配列番号131〜134からなる群から選択されるアミノ酸配列を有するNa1.3ペプチドに結合する、請求項に記載の抗E1イオンチャネル抗体又はその結合断片。 The anti-E1 ion channel antibody or binding fragment thereof according to claim 1 , wherein the antibody or fragment thereof binds to a Na v 1.3 peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs: 131 to 134. 抗体又はその断片が、配列番号135〜138からなる群から選択されるアミノ酸配列を有するNa1.6ペプチドに結合する、請求項に記載の抗E1イオンチャネル抗体又はその結合断片。 The anti-E1 ion channel antibody or a binding fragment thereof according to claim 1 , wherein the antibody or a fragment thereof binds to a Na v 1.6 peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs: 135 to 138. 抗体又はその断片が、配列番号139〜145からなる群から選択されるアミノ酸配列を有するNa1.8ペプチドに結合する、請求項に記載の抗E1イオンチャネル抗体又はその結合断片。 The anti-E1 ion channel antibody or binding fragment thereof according to claim 1 , wherein the antibody or fragment thereof binds to a Na v 1.8 peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs: 139 to 145. 抗体又はその断片が、配列番号146〜149からなる群から選択されるアミノ酸配列を有するNa1.9ペプチドに結合する、請求項に記載の抗E1イオンチャネル抗体又はその結合断片。 The anti-E1 ion channel antibody or binding fragment thereof according to claim 1 , wherein the antibody or fragment thereof binds to a Na v 1.9 peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs: 146 to 149. 抗体が、それが特異的である関連するイオンチャネルの機能を、インビトロパッチクランプアッセイにおいて少なくとも5パーセント阻害する、請求項1からまでのいずれか一項に記載の抗体又は断片。 6. The antibody or fragment according to any one of claims 1 to 5 , wherein the antibody inhibits the function of the relevant ion channel for which it is specific by at least 5 percent in an in vitro patch clamp assay.
JP2015215222A 2009-10-27 2015-10-30 Antibodies against ion channels Expired - Fee Related JP6335152B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25520209P 2009-10-27 2009-10-27
US61/255,202 2009-10-27
GB0922434.6 2009-12-22
GBGB0922434.6A GB0922434D0 (en) 2009-12-22 2009-12-22 antibodies and fragments thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012535812A Division JP5872476B2 (en) 2009-10-27 2010-10-27 Antibodies against ion channels

Publications (3)

Publication Number Publication Date
JP2016020396A JP2016020396A (en) 2016-02-04
JP2016020396A5 true JP2016020396A5 (en) 2016-05-19
JP6335152B2 JP6335152B2 (en) 2018-05-30

Family

ID=55265454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015215222A Expired - Fee Related JP6335152B2 (en) 2009-10-27 2015-10-30 Antibodies against ion channels

Country Status (1)

Country Link
JP (1) JP6335152B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7195879B2 (en) * 2002-04-12 2007-03-27 Ortho-Mcneil Pharmaceutical, Inc. Method for identifying modulators of NAv ion channels
GB0517487D0 (en) * 2005-08-26 2005-10-05 Isis Innovation Antibodies

Similar Documents

Publication Publication Date Title
JP2017048194A5 (en)
JP2018504907A5 (en)
PE20191551A1 (en) DESIGNED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
RU2018132044A (en) ANTIBODIES AGAINST TAU
MX2020013058A (en) Monovalent blood brain barrier shuttle modules.
EA201792245A1 (en) BIOCONJUGATES AND THEIR APPLICATIONS
BR112015022978A8 (en) multimerization technologies
RU2021134101A (en) MODIFIED J-CHAIN
JP2014518898A5 (en)
WO2015143123A3 (en) Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof
AR082149A1 (en) ANTIBODIES AGAINST HUMAN RESPIRATORY SYNTHETIC VIRUS (RSV) AND METHODS FOR USE
UA111818C2 (en) ANTIBODY AGAINST CSF-1R
PH12015501505B1 (en) Antibodies that bind to tl1a and their uses
JP2013539454A5 (en)
CY1122132T1 (en) METHODS OF REDUCING ASTHMA FLASH RATE USING BENRALIZUMAB
IN2014CN04498A (en)
JP2016509011A5 (en)
MY192113A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment of anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
MX2016004579A (en) Tm4sf1 binding proteins and methods of using same.
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
JP2018504911A5 (en)
UA108778C2 (en) ANTI-CANCER Fusion PROTEIN
PH12017500699A1 (en) Antibodies that bind to ccr6 and their uses
WO2015107363A3 (en) Mycobacterial antigen composition
EP4269562A3 (en) Antigen binding molecules and methods of use thereof